Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratumoral Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05122572
What this trial is testing

RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Wuxi People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT05838729
What this trial is testing

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Who this might be right for
Head Neck CancerIntratumoral Injection
Coordination Pharmaceuticals, Inc. 16
Early research (Phase 1)Not Yet RecruitingNCT06217666
What this trial is testing

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Who this might be right for
Pancreatic Adenocarcinoma
Haoming (Carl) Qiu 24
Early research (Phase 1)Looking for participantsNCT07800936
What this trial is testing

HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumors
Parr Biotechnology (Hebei) Co., Ltd. 44
Early research (Phase 1)Study completedNCT03831295
What this trial is testing

SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmExtracranial Solid NeoplasmMetastatic Malignant Solid Neoplasm
Ronald Levy 12
Testing effectiveness (Phase 2)WithdrawnNCT00226993
What this trial is testing

Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.

Who this might be right for
Mycosis Fungoides
Stanford University
Early research (Phase 1)UnknownNCT03982212
What this trial is testing

A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors

Who this might be right for
Cutaneous Squamous Cell CarcinomaSquamous Cell CarcinomaBasal Cell Carcinoma
University of Kansas Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT01253096
What this trial is testing

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 25
Early research (Phase 1)Study completedNCT01672450
What this trial is testing

Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma

Who this might be right for
Melanoma
University of Utah 12
Testing effectiveness (Phase 2)Ended earlyNCT05248789
What this trial is testing

OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer

Who this might be right for
Advanced Bladder Carcinoma
Binhui Biopharmaceutical Co., Ltd. 4
Testing effectiveness (Phase 2)Study completedNCT00365872
What this trial is testing

External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma

Who this might be right for
Soft Tissue Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 17
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Not applicableLooking for participantsNCT06430515
What this trial is testing

The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors

Who this might be right for
Intratumoral InjectionCancer
Wuxi People's Hospital 200
Early research (Phase 1)Ended earlyNCT02890368
What this trial is testing

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Who this might be right for
Solid TumorsMycosis FungoidesMelanoma+5 more
Pfizer 56
Early research (Phase 1)Ended earlyNCT00072098
What this trial is testing

Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Max Sung 22
Early research (Phase 1)UnknownNCT05228119
What this trial is testing

Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
The Affiliated Hospital of Xuzhou Medical University 50
Testing effectiveness (Phase 2)Study completedNCT00880581
What this trial is testing

Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphomas: Non-Hodgkin Follicular / Indolent B-Cell+1 more
Ronald Levy 30
Early research (Phase 1)Looking for participantsNCT06747390
What this trial is testing

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma Virus+1 more
Ryan Carey 30
Testing effectiveness (Phase 2)Ended earlyNCT03065023
What this trial is testing

Study of Intralesional Administration of MK-4621 (RGT100) in Adult Participants With Advanced or Recurrent Tumors (MK-4621-001/RGT100-001)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 15
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Next Page